Coelho, T., Adams, D., Conceição, i., Waddington-Cruz, M., Schmidt, H. H., Buades, J., . . . Suhr, O. B. (2021). A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis.
Chicago Style (17th ed.) CitationCoelho, Teresa, et al. A Phase II, Open-label, Extension Study of Long-term Patisiran Treatment in Patients with Hereditary Transthyretin-mediated (hATTR) Amyloidosis. 2021.
MLA (8th ed.) CitationCoelho, Teresa, et al. A Phase II, Open-label, Extension Study of Long-term Patisiran Treatment in Patients with Hereditary Transthyretin-mediated (hATTR) Amyloidosis. 2021.
Warning: These citations may not always be 100% accurate.